SEATTLE--(BUSINESS WIRE)-- Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10 ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy ...

Know Labs’ first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor’s accuracy and medical application. SEATTLE--(BUSINESS WIRE) ...

SEATTLE--(BUSINESS WIRE)-- Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment ...

Greetings, and welcome to the Know Labs First Quarter 2024 Earnings Conference Call. Please note this conference call is being recorded. You may submit questions through the Q&A box on the webcast at ...

Company to Drive Monetization of its Patented Platform Technology Across Diverse Industries The launch of KTL represents a pivotal milestone in Know Labs’ strategic growth plan. While the company ...

Know Labs has put forward additional proof-of-concept data from its needle-free blood sugar monitor, designed to continuously scan the blood through a person’s skin. The company said its digital, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Seattle-based Know Labs, which ...

Know Labs, Inc. (NYSE American: KNW) (“Know Labs”or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today issued a reminder to its stockholders to vote ...

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, through its patented and patent pending electromagnetic energy technology platforms, announced today that it ...